TL;DR
This study reveals that phosphorylation significantly increases the mechanical stiffness of utrophin, a protein being explored as a therapy for Duchenne muscular dystrophy. This finding suggests that post-translational modifications could be a key mechanism for tuning utrophin's mechanical properties to better mimic dystrophin's shock-absorbing function.
What Problem Does This Paper Address?
Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration, primarily caused by the absence of the protein dystrophin. Dystrophin is thought to act as a molecular shock absorber, stabilizing the muscle cell membrane (sarcolemma) against mechanical stress. Utrophin, a homologous protein, is a promising therapeutic candidate for DMD because it is naturally present in healthy muscle and can partially compensate for dystrophin deficiency. However, previous studies have shown that full-length utrophin expressed in eukaryotic cells appears mechanically "stiffer" than dystrophin fragments expressed in bacteria. This discrepancy raises questions about whether utrophin can truly replicate dystrophin's mechanical role and whether differences in expression systems (e.g., post-translational modifications) are responsible for the observed stiffness differences. This paper aims to investigate how the expression system and post-translational modifications, specifically phosphorylation, affect the mechanical properties of a model utrophin fragment.
Methods
The researchers employed a multi-pronged approach to investigate the mechanical properties of utrophin fragments:
- Atomic Force Microscopy (AFM): This technique was used to directly measure the mechanical forces required to unfold individual protein molecules. By "pulling" on single utrophin fragments, they could quantify their stiffness and identify unfolding events.
- Circular Dichroism (CD) Spectroscopy: CD spectroscopy was used to assess the secondary structure and thermal stability of the protein fragments. This helped determine if differences in expression systems affected the protein's overall folding and stability.
- Mass Spectrometry: This was crucial for identifying post-translational modifications, particularly phosphorylation sites, on the utrophin fragments. They compared fragments expressed in different systems to pinpoint where and if phosphorylation occurred.
- Pro-Q Diamond Phosphoprotein Stain: This biochemical stain was used as an initial screen to detect the presence of phosphorylated proteins.
- Site-Directed Mutagenesis: To test the role of specific phosphorylation sites, researchers mutated serine residues to alanine (to prevent phosphorylation) or to glutamic acid (to mimic phosphorylation).
- Actin Cosedimentation Assay: This assay was used to measure the binding affinity of utrophin fragments to actin filaments, ensuring that any observed changes in mechanical properties did not affect this crucial interaction.
Datasets
Not discussed in the paper. The study focuses on in vitro experiments using purified recombinant proteins.
Key Insights and Ideas
- Expression System Matters: The mechanical stiffness of a utrophin fragment (UtrN-R3) is significantly influenced by whether it's expressed in bacterial or eukaryotic (insect) cells. Eukaryotic expression leads to a stiffer protein.
- Phosphorylation is the Key: The increased stiffness observed in eukaryotic-expressed utrophin is directly linked to phosphorylation. Bacterial UtrN-R3, which is not phosphorylated, is less stiff.
- Specific Sites are Critical: Phosphorylation at serine residues S19 and S295 appears to be particularly important for increasing utrophin's mechanical stiffness. Mutating these sites to alanine reduced stiffness to levels comparable to unphosphorylated bacterial protein.
- Mimicking Phosphorylation Restores Stiffness: Replacing serine residues with glutamic acid (to mimic a phosphorylated state) in bacterial UtrN-R3 increased its stiffness, bringing it closer to that of the insect-expressed, phosphorylated protein.
- Actin Binding Unaffected: Crucially, phosphorylation does not alter utrophin's ability to bind to actin filaments, suggesting that its mechanical function can be modulated independently of its actin-binding role.
- Utrophin and Dystrophin are More Similar Than Previously Thought: When compared within the same experimental system, utrophin and dystrophin fragments show more similar mechanical stiffness than suggested by studies using different expression systems.
Key Results
- Insect cell-expressed UtrN-R3 exhibited significantly higher unfolding forces (median ~122 pN) compared to bacterial UtrN-R3 (median ~87 pN).
- Mass spectrometry identified phosphorylation on multiple serine residues (S19, S206, S295, S465, S612) in insect-expressed UtrN-R3, while bacterial UtrN-R3 showed no detectable phosphorylation.
- Mutating S19 or S295 to alanine in insect UtrN-R3 significantly reduced its unfolding forces, bringing them down to levels similar to bacterial UtrN-R3.
- Mimicking phosphorylation at S19 and S29 by mutating them to glutamic acid in bacterial UtrN-R3 increased its unfolding forces, approaching those of insect UtrN-R3.
- The actin-binding affinity (Kd) for both insect and bacterial UtrN-R3 was comparable, with no significant difference observed.
Limitations and Future Work
- Mechanism of Stiffness Increase: While the study demonstrates that phosphorylation increases stiffness, the precise molecular mechanism by which this occurs remains to be fully elucidated. The authors speculate that electrostatic interactions mediated by the phosphate group could play a role, potentially forming salt bridges.
- In Vivo Relevance: The study uses a model fragment (UtrN-R3) and in vitro experiments. Future work should investigate how these findings translate to full-length utrophin in vivo and its role in muscle.
- Therapeutic Implications: The authors suggest that modulating utrophin's phosphorylation status could be a strategy to enhance its efficacy as a DMD therapy. Further research is needed to explore how this could be achieved pharmacologically or genetically.
- Comparison with Dystrophin: While the study shows that bacterial UtrN-R3 and a dystrophin fragment (DysR8-15) have similar stiffness, a direct comparison of phosphorylated utrophin with phosphorylated dystrophin would be valuable.
Summary updated